Dr. Abraham currently serves as Senior Vice President and Chief Innovation Officer and is responsible for the development of machine learning algorithms via DEAN (Deliberation Analytics), an advanced AI platform that powers blood-based diagnostic assay development, drug target discovery, tumor type assessment and therapeutic selection. He is an inventor on multiple groundbreaking patents involving novel algorithms and predictive signatures, which is ushering in the new era of next generation profiling in precision medicine.
Dr. Abraham joined Caris Life Sciences in 2007 in Information Technology and has since held several management positions with increasing responsibilities. He began his career developing the vast majority of data models and systems driving Caris’ pursuits in precision medicine today. He then moved on to lead the Cognitive Computing group where he was instrumental in helping to identify new biological signatures to improve cancer diagnosis and treatment selection. Dr. Abraham received his bachelor’s degree in Neurobiology from the University of Texas at Austin, pursued post graduate education in Biomedical Informatics at Stanford University and earned his PhD in Cell & Molecular Biology at Arizona State University.